Immunoassay with cytomegalovirus early antigens from gene products p52 and CM<sub>2</sub> (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome

200740 citationsJournal Article

Authors

A. Martin Lerner · Wayne State University

James T. Fitzgerald · University of Michigan–Ann Arbor

Abstract

Immunoassays that use early antigen recombinant HCMV CM(2) and p52 are five times more sensitive than HCMV ELISA assay using viral lysate, and are specific in the detection and differentiation of active HCMV infection in a subset of patients with CFS.

Topics & Keywords

Fibromyalgia and Chronic Fatigue Syndrome Research Long-Term Effects of COVID-19 Olfactory and Sensory Function Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Pathology

Volume 61, Issue 5, pp. 623-626

DOI: 10.1136/jcp.2007.050633

Field-Weighted Citation Impact: 1.76